Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

117
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
117
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

113
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
113

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biomaterial-guided macrophage modulation: Therapeutic engineering of immune microenvironments.

Trends in immunology·2026
Same author

Cytokine co-presentation on targeted lipid nanoparticles enhances in vivo T cell engineering.

Biomaterials·2026
Same author

Charge localization, rectification, and transport in electrolyte patchy nanochannels.

Faraday discussions·2026
Same author

Metamemory and Emotional Contributions to the Relationship Between Cognitive Function and Medication Adherence in H-Type Hypertension: A Cross-Sectional Mediation Analysis.

Patient preference and adherence·2026
Same author

N<sup>4</sup>-Acetylcytidine enhances synthetic mRNA translation yield and fidelity.

Nature·2026
Same author

Sinomenine protects mice against <i>Staphylococcus aureus</i>-induced endometritis through inhibition of P2X7 receptor-mediated ferroptosis and inflammation.

Microbiology spectrum·2026

Related Experiment Video

Updated: Apr 11, 2026

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA
08:29

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Published on: February 1, 2019

10.8K

Controlling Payload Heterogeneity in Lipid Nanoparticles for RNA-Based Therapeutics.

Turash Haque Pial1, Sixuan Li2, Jinghan Lin1,3,4

  • 1Department of Materials Science and Engineering, Johns Hopkins University, Baltimore.

Advanced Functional Materials
|April 10, 2026
PubMed
Summary

Uniform lipid nanoparticles (LNPs) improve gene silencing. Optimizing LNP assembly via controlled mixing and formulation enhances RNA loading, leading to more effective nucleic acid therapies.

Keywords:
Lipid nanoparticlesRNA encapsulationRNA payload distributionRNA therapeuticskinetic Monte Carlosingle-particle characterization

More Related Videos

Author Spotlight: Enhancing Lipid Nanoparticle Formation Through Turbulent Mixing in Confined Geometries
08:10

Author Spotlight: Enhancing Lipid Nanoparticle Formation Through Turbulent Mixing in Confined Geometries

Published on: August 23, 2024

6.7K
Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing
08:55

Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing

Published on: January 20, 2023

15.2K

Related Experiment Videos

Last Updated: Apr 11, 2026

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA
08:29

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Published on: February 1, 2019

10.8K
Author Spotlight: Enhancing Lipid Nanoparticle Formation Through Turbulent Mixing in Confined Geometries
08:10

Author Spotlight: Enhancing Lipid Nanoparticle Formation Through Turbulent Mixing in Confined Geometries

Published on: August 23, 2024

6.7K
Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing
08:55

Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing

Published on: January 20, 2023

15.2K

Area of Science:

  • Biotechnology
  • Nanomedicine
  • Molecular Biology

Background:

  • Lipid nanoparticles (LNPs) are crucial for nucleic acid delivery.
  • Conventional LNP assembly methods result in heterogeneous payload distribution, reducing therapeutic efficacy.
  • Heterogeneous siRNA distribution within LNPs impairs gene knockdown efficiency.

Purpose of the Study:

  • To investigate the origins and extent of payload heterogeneity in LNPs.
  • To elucidate the self-assembly dynamics governing RNA-LNPs.
  • To develop design principles for uniform and potent LNP-based therapies.

Main Methods:

  • Coarse-grained molecular dynamics simulations
  • Kinetic Monte Carlo simulations
  • Cylindrical illumination confocal spectroscopy
  • Machine learning analysis
  • Turbulent mixing optimization

Main Results:

  • Payload heterogeneity is driven by the interplay between RNA diffusion kinetics and lipid self-assembly.
  • Controlled turbulent mixing significantly reduces LNP payload variance and improves RNA distribution uniformity.
  • Salt concentration and PEG-lipid content modulate RNA loading in a volume-dependent manner.

Conclusions:

  • Understanding LNP self-assembly is key to controlling payload distribution.
  • Optimized LNP formulation and mixing enhance therapeutic potency and safety.
  • Actionable design principles for advanced LNP-based nucleic acid therapies were established.